Robeco Institutional Asset Management B.V. Ironwood Pharmaceuticals Inc Transaction History
Robeco Institutional Asset Management B.V.
- $49.7 Billion
- Q3 2024
A detailed history of Robeco Institutional Asset Management B.V. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 380,960 shares of IRWD stock, worth $1.34 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
380,960
Previous 27,336
1293.62%
Holding current value
$1.34 Million
Previous $178,000
779.21%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IRWD
# of Institutions
238Shares Held
162MCall Options Held
11.2MPut Options Held
9.1K-
Black Rock Inc. New York, NY22.9MShares$80.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA22MShares$77.8 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$57.9 Million16.75% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.3MShares$39.8 Million0.11% of portfolio
-
State Street Corp Boston, MA9.92MShares$35 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $541M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...